Why KRYS? Krystal Biotech, Inc. Analysis, Price & AI Insights | Whystock
KRYS
$266.04+3.78 (+1.44%)
Pre-Market$274.00+7.96 (+2.99%)· Last close May 1
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.